Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06738719
What this trial is testing

Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Moderately to Severely Active Rheumatoid Arthritis
Celltrion 192
Testing effectiveness (Phase 2)UnknownNCT06306339
What this trial is testing

Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug)

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
ImmuneMed, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT03001219
What this trial is testing

RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 109
Large-scale testing (Phase 3)Study completedNCT02873936
What this trial is testing

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 449
Early research (Phase 1)Ended earlyNCT06087406
What this trial is testing

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, RheumatoidArthritis
IGM Biosciences, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT02287922
What this trial is testing

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 251
Large-scale testing (Phase 3)Study completedNCT00106574
What this trial is testing

Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,220
Large-scale testing (Phase 3)Study completedNCT02114931
What this trial is testing

Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Amgen 467
Not applicableUnknownNCT04449224
What this trial is testing

Comparative Effectiveness of Targeted Therapy in RA Patients

Who this might be right for
Rheumatoid Arthritis
Hanyang University 506
Post-approval studies (Phase 4)Study completedNCT04928066
What this trial is testing

The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Who this might be right for
Arthritis, Rheumatoid
Qilu Hospital of Shandong University 100
Testing effectiveness (Phase 2)Study completedNCT01888874
What this trial is testing

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 599
Testing effectiveness (Phase 2)Study completedNCT04413617
What this trial is testing

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Who this might be right for
Rheumatoid Arthritis
Pfizer 460
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Testing effectiveness (Phase 2)Study completedNCT04049448
What this trial is testing

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 40
Testing effectiveness (Phase 2)Study completedNCT04192617
What this trial is testing

Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
SinoMab BioScience Ltd 156
Not applicableStudy completedNCT01649817
What this trial is testing

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 183
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Not applicableStudy completedNCT03387423
What this trial is testing

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,459
Testing effectiveness (Phase 2)Study completedNCT05279417
What this trial is testing

ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Aclaris Therapeutics, Inc. 251
Post-approval studies (Phase 4)Ended earlyNCT01251120
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 2
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation